↓ Skip to main content

Validating GWAS Variants from Microglial Genes Implicated in Alzheimer’s Disease

Overview of attention for article published in Journal of Molecular Neuroscience, May 2017
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (77th percentile)
  • Good Attention Score compared to outputs of the same age and source (72nd percentile)

Mentioned by

news
1 news outlet

Citations

dimensions_citation
9 Dimensions

Readers on

mendeley
32 Mendeley
Title
Validating GWAS Variants from Microglial Genes Implicated in Alzheimer’s Disease
Published in
Journal of Molecular Neuroscience, May 2017
DOI 10.1007/s12031-017-0928-7
Pubmed ID
Authors

Lígia Ramos dos Santos, Lúcia Helena Sagrillo Pimassoni, Geralda Gillian Silva Sena, Daniela Camporez, Luciano Belcavello, Maíra Trancozo, Renato Lírio Morelato, Flavia Imbroisi Valle Errera, Maria Rita Passos Bueno, Flavia de Paula

Abstract

Late-onset Alzheimer's disease (LOAD) is a multifactorial neurodegenerative disorder that corresponds to most Alzheimer's disease (AD) cases. Inflammation is frequently related to AD, whereas microglial cells are the major phagocytes in the brain and mediate the removal of Aβ peptides. Microglial cell dsyregulation might contribute to the formation of amyloid plaques, a hallmark of AD. Genome-wide association studies have reported genetic loci associated with the inflammatory pathway involved in AD. Among them, rs3865444 CD33, rs3764650 ABCA7, rs6656401 CR1, and rs610932 MS4A6A variants in microglial genes are associated with LOAD. These variants are proposed to participate in the clearance of Aβ peptides. However, their association with LOAD was not validated in all case-control studies. Thus, the present work aimed to assess the involvement of CD33 (rs3865444), ABCA7 (rs3764650), CR1 (rs6656401), and MS4A6A (rs610932) with LOAD in a sample from southeastern Brazil. The genotype frequencies were assessed in 79 AD patients and 145 healthy elders matched for sex and age. We found that rs3865444 CD33 acts as a protective factor against LOAD. These results support a role for the inflammatory pathway in LOAD.

Mendeley readers

The data shown below were compiled from readership statistics for 32 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 32 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 9 28%
Student > Ph. D. Student 6 19%
Student > Master 5 16%
Unspecified 3 9%
Student > Postgraduate 3 9%
Other 6 19%
Readers by discipline Count As %
Unspecified 11 34%
Agricultural and Biological Sciences 7 22%
Neuroscience 6 19%
Biochemistry, Genetics and Molecular Biology 2 6%
Computer Science 1 3%
Other 5 16%

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 May 2017.
All research outputs
#1,493,626
of 9,896,588 outputs
Outputs from Journal of Molecular Neuroscience
#63
of 681 outputs
Outputs of similar age
#57,419
of 263,550 outputs
Outputs of similar age from Journal of Molecular Neuroscience
#7
of 25 outputs
Altmetric has tracked 9,896,588 research outputs across all sources so far. Compared to these this one has done well and is in the 84th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 681 research outputs from this source. They receive a mean Attention Score of 2.5. This one has done well, scoring higher than 88% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 263,550 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 77% of its contemporaries.
We're also able to compare this research output to 25 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.